MLICM
ATOS icon

Metropolitan Life Insurance Company (MetLife)’s Atossa Therapeutics ATOS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,031
Closed -$50.4K – 2785
2021
Q3 		$50.4K Sell
1,031
-1,215
-54% -$70.7K ﹤0.01% 2759
2021
Q2 		$213K Buy
+2,246
New +$119K ﹤0.01% 2097

Other funds holding ATOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ATOS Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Atossa Therapeutics (ATOS) in Q4 2021, closing a stake of 1,031 shares — an estimated $50.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ATOS in Q2 2021 and held it in 2 quarters. The position peaked at $213K in Q2 2021. 92 funds tracked by Wall St. Rank hold ATOS as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Atossa Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,031 Atossa Therapeutics shares in Q4 2021, an estimated $50.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Atossa Therapeutics in Q2 2021 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Atossa Therapeutics position peaked at $213K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.